🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Namilumab

    Takeda

    Rheumatoid Arthritis

    phase 2 small molecule completed

    2 trials

  2. Ninlaro

    Takeda

    Immune Thrombocytopenia

    phase 2 small molecule terminated

    1 trial

  3. Niraparib

    Takeda

    Ovarian Cancer

    phase 2 small molecule completed

    2 trials

  4. Niraparib

    Takeda

    Efficacy

    phase 2 small molecule active

    1 trial

  5. Niraparib-Bevacizumab

    Takeda

    Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor

    phase 2 small molecule active

    1 trial

  6. Nivolumab

    Takeda

    Relapsed Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  7. NoV GI.1/GII.4 Bivalent VLP Vaccine

    Takeda

    Norovirus

    phase 2 mab completed

    1 trial

  8. NoV Placebo-matching Saline

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial

  9. NoV Vaccine

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial

  10. Norovirus Bivalent VLP Vaccine

    Takeda

    Norovirus Prevention

    phase 2 mab completed

    1 trial

  11. Norovirus Bivalent Vaccine

    Takeda

    Prevention From Norovirus Infection

    phase 2 mab completed

    1 trial

  12. Norovirus GI.1/GII.4 Bivalent VLP Vaccine

    Takeda

    Norovirus

    phase 2 mab completed

    1 trial

  13. Norwalk VLP vaccine

    Takeda

    Acute Gastroenteritis

    phase 2 mab completed

    1 trial

  14. Ondansetron

    Takeda

    Nausea

    phase 2 small molecule completed

    1 trial

  15. Oral Budesonide Suspension (MB-9)

    Takeda

    Eosinophilic Esophagitis (EoE)

    phase 2 small molecule completed

    1 trial

  16. Orteronel 300mg BID

    Takeda

    Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors

    phase 2 small molecule terminated

    1 trial

  17. PF-00547659

    Takeda

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  18. PF-00547659 SC injection

    Takeda

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  19. PVS-10200

    Takeda

    Peripheral Artery Disease

    phase 2 mab completed

    1 trial

  20. Paclitaxel

    Takeda

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  21. Paclitaxel

    Takeda

    Endometrial Neoplasms

    phase 2 small molecule completed

    1 trial

  22. Paclitaxel and TAK-228

    Takeda

    Metastatic Urothelial Cancer

    phase 2 other active

    1 trial

  23. Pacritinib

    Takeda

    Primary Myelofibrosis

    phase 2 mab terminated

    1 trial

  24. Panitumumab

    Takeda

    Squamous Cell Carcinoma of Head and Neck

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources